The stock of ABVC BioPharma Inc (NASDAQ: ABVC) has decreased by -7.14 when compared to last closing price of 1.12. Despite this, the company has experienced a -8.77% fall in its stock price over the last five trading sessions. PennyStocks reported 2023-10-26 that If you’re wondering what is going on in the stock market today or which penny stocks to buy now that major indexes are lower, you’re not alone. Earnings season mixed with economic data has resulted in a sharp downturn for the market.
Is It Worth Investing in ABVC BioPharma Inc (NASDAQ: ABVC) Right Now?
ABVC has 36-month beta value of 0.78. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ABVC is 8.68M, and currently, short sellers hold a 15.17% ratio of that float. The average trading volume of ABVC on April 17, 2024 was 710.02K shares.
ABVC’s Market Performance
The stock of ABVC BioPharma Inc (ABVC) has seen a -8.77% decrease in the past week, with a -10.34% drop in the past month, and a -19.38% fall in the past quarter. The volatility ratio for the week is 10.09%, and the volatility levels for the past 30 days are at 8.30% for ABVC. The simple moving average for the past 20 days is -12.17% for ABVC’s stock, with a -36.08% simple moving average for the past 200 days.
ABVC Trading at -15.12% from the 50-Day Moving Average
After a stumble in the market that brought ABVC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -89.17% of loss for the given period.
Volatility was left at 8.30%, however, over the last 30 days, the volatility rate increased by 10.09%, as shares sank -6.25% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -25.00% lower at present.
During the last 5 trading sessions, ABVC fell by -7.89%, which changed the moving average for the period of 200-days by -79.79% in comparison to the 20-day moving average, which settled at $1.1805. In addition, ABVC BioPharma Inc saw -10.34% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ABVC
Current profitability levels for the company are sitting at:
- -53.9 for the present operating margin
- -1.03 for the gross margin
The net margin for ABVC BioPharma Inc stands at -57.51. The total capital return value is set at -0.91. Equity return is now at value -158.22, with -80.41 for asset returns.
Based on ABVC BioPharma Inc (ABVC), the company’s capital structure generated 0.22 points at debt to capital in total, while cash flow to debt ratio is standing at -1.72. The debt to equity ratio resting at 0.28. The interest coverage ratio of the stock is -3.3.
Currently, EBITDA for the company is -8.19 million with net debt to EBITDA at -0.22. When we switch over and look at the enterprise to sales, we see a ratio of 84.12. The receivables turnover for the company is 0.2for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.28.
Conclusion
To put it simply, ABVC BioPharma Inc (ABVC) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
